Letter to the editor: Circulating thrombospondinâ2 as a biomarker in patients with NAFLD with and without diabetesâAre we convinced yet?
Sign Up to like & getrecommendations! Published in 2022 at "Hepatology"
DOI: 10.1002/hep.32353
Abstract: To the editor, We read with interest the study by Kozumi et al. which demonstrated, using hepatic transcriptome profiling of liver tissues from patients with NAFLD, that the thrombospondin2 (TSP2) gene was most significantly upregulated… read more here.
Keywords: biomarker; patients nafld; fibrosis; editor ... See more keywords